But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse. So should Vivoryon Therapeutics (AMS:VVY) ...

If you're interested in Vivoryon Therapeutics AG (AMS:VVY), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your ...

Vivoryon Therapeutics N.V. Annual stock financials by MarketWatch. View the latest VVY financial statements, income statements and financial ratios.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The average one-year price target for Vivoryon Therapeutics N.V. (AMS:VVY) has been revised to 51.51 / share. This is an increase of 16.76% from the prior estimate of 44.12 dated April 23, 2023. The ...

Vivoryon Therapeutics N.v. is listed on the Euronext Amsterdam trading with ticker code VVY.AM. It has a market capitalisation of €37.76m, with approximately 29.61m shares in issue. Over the last year ...

At close: 5:23:38 pm GMT+1 ...

We believe one of the main reasons for the devaluation of Probiodrug AG (AS:PDB) shares over the past year was the largely ...

At close: 2 April at 5:35:00 pm GMT+2 ...

As of 2:16:25 pm GMT+1. Market open.

As of 10:53:44 CET. Market open.